Skip to main content
Peter Izmirly, MD, Rheumatology, New York, NY

PeterM.IzmirlyMD

Rheumatology • New York, NY

Assistant Professor, Medicine, New York University School of Medicine

Join to view full profile

Dr. Izmirly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Izmirly's full profile

Already have an account?

  • Office

    560 1st Ave
    # Nyu
    New York, NY 10016
    Phone+1 212-263-0745

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Rheumatology, 2004 - 2007
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Internal Medicine, 2001 - 2004
  • New York University School of Medicine
    New York University School of MedicineClass of 2001

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2026
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • A Prospective International Study on Adherence to Treatment in 305 Patients with Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires  
    Peter Izmirly, Michelle Petri, Meenakshi Jolly, Jill Buyon, Clinical Pharmacology & Therapeutics

Lectures

  • Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers 
    76th Annual Scienific Meeting, Washington, DC, USA

Authored Content

  • Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive MothersJuly 2020
  • Tubulointerstitial Damage Predicts End Stage Renal Disease in Lupus Nephritis with Preserved to Moderately Impaired Renal Function: A Retrospective Cohort StudyFebruary 2018

Press Mentions

  • MCTD: Is It Just Letters?
    MCTD: Is It Just Letters?December 4th, 2024
  • Patients with Lupus Benefit from COVID-19 Vaccine Booster – ScienceDaily
    Patients with Lupus Benefit from COVID-19 Vaccine Booster – ScienceDailyJuly 13th, 2022
  • COVID-19 Booster Vaccine Beneficial for Lupus Patients: Study
    COVID-19 Booster Vaccine Beneficial for Lupus Patients: StudyJuly 13th, 2022
  • Join now to see all

Professional Memberships

Dr. Peter Izmirly, Dr. Peter Izmirly, MD, Dr. P Izmirly, Dr. Peter M. Izmirly